Media Coverage: Scripps MD Anderson Treats Patient with New Cancer Therapy
Note to Patients: The following news is posted for archival purposes only. Scripps no longer has a formal partnership with MD Anderson Cancer Center. We currently provide comprehensive cancer care through Scripps Cancer Center.
Local man is first in San Diego County to receive new drug
![William Apodaca, cancer patient, and Dr. Marin Xavier, oncologist at Scripps MD Anderson Cancer Center.](http://www.scripps.org/sparkle-assets/images/scripps_md_anderson_patient_william_apodaca_and_dr_marin_xavier_1200x750-f78509744f7497ed09725f16f0cf4dab.jpg)
Cancer patient William Apodaca and Dr. Marin Xavier, medical oncologist at Scripps MD Anderson Cancer Center and a physician with Scripps Clinic Medical Group
Local man is first in San Diego County to receive new drug
A San Diego man with a rare form of cancer was recently treated at Scripps MD Anderson Cancer Center with a new targeted cancer therapy. William Apodaca of Paradise Hills received a dose of the radioactive drug Lutathera at Scripps Mercy Hospital San Diego, making him the first patient in the region to receive the new FDA-approved medication.
“This medication is pretty much giving me a second chance at life,” Apodaca told 10 News.
View the segment on 10 News: San Diego patient treated with new targeted cancer therapy
Read the story in The San Diego Union-Tribune: Drug effective against cancer that killed Steve Jobs arrives in San Diego
The segment on KUSI, “Cancer Treatment Milestone at Scripps MD Anderson,” is no longer available.
Media Contact
- Steve Carpowich
- 858-312-0328
- carpowich.stephen@scrippshealth.org
- Follow me: @Carpowich